Drug
Investigational Influenza Vaccine
Investigational Influenza Vaccine: highest development phase Phase 1/2, developed by BioNTech. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- BioNTech
Trials
| Drug | Phase | Indication |
|---|---|---|
| Investigational Influenza Vaccine NCT06683352 | Phase 1/2 | Influenza,Human |
| Investigational Influenza Vaccine NCT06821061 | Phase 1/2 | Influenza |
Latest
No recent events.
Follow Investigational Influenza Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.